TrialGut2021

EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers.

Elizabeth C Smyth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.